Reciprocally, endocrine‐resistant breast cancer cells activate the mTORC1‐FOXK1 pathway of macrophages by altering amino acid metabolism in the microenvironment, which enhances M2 macrophage polarization and CCL2 secretion by macrophages. This evidence concerns the gene CCL2 and breast cancer.